Bellevue Life Sciences Acquisition News

OSR Holdings and SillaJen Have Entered Into a Memorandum of Understanding to Collaboratively Pursue the Development of Innovative Therapeutics and Enter the U.S. Market

PRNewswireApr 22 08:00 ET

SPAC Bellevue Life Sciences to Merge With South Korea's OSR

Seeking AlphaNov 20, 2023 12:28 ET

Bellevue Life Sciences Acquisition: Shares of Combined Co., OSR Biosciences, Inc., Expected to Trade on Nasdaq >BLACU

Bellevue Life Sciences Acquisition: Shares of Combined Co., OSR Biosciences, Inc., Expected to Trade on Nasdaq >BLACU

Dow JonesNov 16, 2023 17:02 ET

OSR Holdings Co., Ltd. Enters Into Business Combination Agreement With Bellevue Life Sciences Acquisition Corp.

Bellevue Life Sciences Acquisition Corp. (Nasdaq: BLAC), a publicly traded special purpose acquisition company ("BLAC"), and OSR Holdings Co., Ltd....

PR NewswireNov 16, 2023 17:00 ET

Bellevue Life Sciences Acquisition Plans to Take OSR Holdings Public in SPAC Merger Deal

Bellevue Life Sciences Acquisition (BLAC), a blank-check company, signed an exclusive nonbinding letter of intent to merge with OSR Holdings in a deal that would take the health-care company public. B

MT NewswiresJul 11, 2023 17:27 ET

Express News | OSR Holdings Expected to Be Public in the 4Q >BLACU

Moomoo 24/7Jul 11, 2023 16:46 ET

Express News | Bellevue Life Sciences Acquisition Corp. and OSR Holdings: Sign an Exclusive Letter of Intent for a Business Combination

Moomoo 24/7Jul 11, 2023 16:46 ET

Bellevue Life Sciences Acquisition Corp. and OSR Holdings Sign an Exclusive Letter of Intent for a Business Combination

OSR Holdings expected to be public in the fourth quarter of 2023 BELLEVUE, Wash. and SEOUL, South Korea, July 11, 2023 /PRNewswire/ -- Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC), a publicly traded special

PR NewswireJul 11, 2023 16:45 ET

Bellevue Life Sciences Acquisition Corp. Announces Separate Trading of Its Shares of Common Stock, Warrants and Rights Commencing March 17, 2023

BELLEVUE, Wash., March 14, 2023 /PRNewswire/ -- Bellevue Life Sciences Acquisition Corp. (the "Company") announced that holders of the 6,900,000 units sold in the Company's initial public offering, i

PR NewswireMar 14, 2023 16:18 ET

Bellevue Life Sciences Acquisition Corp. Announces Closing of $60 Million Initial Public Offering

BELLEVUE, Wash., Feb. 14, 2023 /PRNewswire/ -- Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLACU, the ", Company", )), a newly organized blank check company incorporated in Delaware, today announced that it

PR NewswireFeb 14, 2023 16:12 ET

Bellevue Life Sciences Acquisition Corp. Announces Pricing of $60 Million Initial Public Offering

BELLEVUE, Wash., Feb. 10, 2023 /PRNewswire/ -- Bellevue Life Sciences Acquisition Corp. (the "Company") today announced the pricing of its initial public offering of 6,000,000 units at a price of $10.00 per unit.

PR NewswireFeb 10, 2023 02:51 ET

Bellevue Life Sciences Acquisition Corp.: Each Unit Consists of One Share, One Redeemable Warrant and One Right

Bellevue Life Sciences Acquisition Corp.: Each Unit Consists of One Share, One Redeemable Warrant and One Right

Dow JonesFeb 10, 2023 00:40 ET

BRIEF-Blank Check Co, Bellevue Life Sciences Acquisition Corp Files For IPO Of Up To $60 Million - SEC Filing

April 29 (Reuters) - Bellevue Life Sciences Acquisition Corp:* BLANK CHECK CO, BELLEVUE LIFE SCIENCES ACQUISITION CORP FILES FOR IPO OF UP TO $60 MILLION - SEC FILING* BELLEVUE LIFE SCIENCES ACQUISITI

ReutersApr 29, 2022 18:01 ET